2026³â 02¿ù 15ÀÏ ÀÏ¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > ´º½ºÁö´åÄÄ > Science & Technology

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
- - - - - - -
 

Arthur D. Little and Vega IT Unveil Joint Venture for Digital Innovation

´º½ºÀÏÀÚ: 2026-01-01

NEW YORK -- Arthur D. Little (ADL) and Vega IT announced the formation of Axceler8 Solutions, a 50/50 joint venture created to design, develop, and operate a portfolio of digital and AI solutions aimed at improving efficiency and automating complex business processes. The launch of this new company is the direct outcome of a year of successful collaboration between the two firms and marks a new phase in their shared ambition to bring scalable, high-performance digital solutions to market, aiming to further augment their clients’ capacity to compress time to impact in a variety of domains.

Axceler8 Solutions’ first product, Axceler8 Rx, is now live as a newly developed platform, and is a cloud-based application designed for pharmaceutical sponsors to accelerate clinical trial design, optimize country and site selection, and simulate patient enrolment. It combines ADL’s proprietary clinical trial IP and domain expertise with Vega IT’s software engineering capabilities and global experience in delivering innovative digital solutions in the healthcare sector. Key modules already delivered cover trial site selection, site activation, enrolment forecasting and an overall dashboard to visualize all aspects of clinical trial progress.

The underlying Axceler8 Rx platform is built on a modular, sector-agnostic architecture, enabling rapid development of future applications. This flexible foundation is designed to scale, supporting clients as they tackle evolving digital challenges. The two firms will work together to ensure a seamless global rollout of the platform, from providing consulting and commercialization expertise to systems integration and managed services.

Ignacio Garcia Alves, Chairman and CEO at Arthur D. Little, comments, “Axceler8 Solutions represents the next step in our partnership with Vega IT, one that turns powerful ideas into high-performance platforms. Together, we are bringing speed, scale, and intelligence to sectors that need it most, starting with life sciences.”

Sasa Popovic, CEO of Vega IT, adds, “Axceler8 Solutions is built for scale, speed, and impact. Our goal is to turn complexity into clarity for our clients, delivering smart, sector-ready solutions through a flexible, reusable platform.”

Philippe Mauchard, Chief Bridge Officer at Arthur D. Little concludes, “This joint venture is an important milestone in our Open Consulting strategy, strengthening our ability to equip clients for faster impact in AI and digital, through a set of complementary partnerships with leading organizations such as Vega IT.”



 Àüü´º½º¸ñ·ÏÀ¸·Î

Lenovo Brings Real-Time Store Visibility and AI-Driven Support to Retail—Delivering Value on Day One
Blue Shift Report Highlights Systemic Vulnerabilities Caused by the Hidden Cost of AI
Australian Defence Force Secures Satellite Communications on SES IS-22
BlueMatrix and Perplexity Partner to Bring AI-Powered Discovery to Institutional Research
KIOXIA SSDs Achieve Compatibility with Microchip¡¯s Adaptec¢ç SmartRAID 4300 Series RAID Storage Accelerator
FDA Accepts New Drug Application for Pimicotinib for the Treatment of Tenosynovial Giant Cell Tumor
ACCELQ Crowned Leader and Customer Favorite in The Forrester Wave¢â for Autonomous Testing Platforms

 

Rigaku Launches ONYX 3200, a Metrology Instrument for Semiconductor Ma...
IntelliVIX Showcases ¡®K-AI¡¯ Prowess at CES 2026, Accelerating Global...
BeOne Medicines Highlights Global Oncology Leadership at 44th Annual J...
Interactive Brokers Redesigns IBKR GlobalTrader App for Simpler, Smart...
MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of M...
Biocytogen, Acepodia Expand Collaboration on Option-Based Framework fo...
Lenovo Launches Agentic AI and xIQ to Drive Scalable Full-Lifecycle Hy...

 


°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ

 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..